{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T13:04:15Z","timestamp":1779714255556,"version":"3.53.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Biphenotypic sinonasal sarcoma (BSNS) is usually histologically distinguishable in its conventional form based on morphology and ancillary studies. However, a subset of BSNS loses characteristic histologic features over time and instead undergoes high-grade rhabdomyosarcomatous transformation (HGRT). The fact that the driver\n                      <jats:italic>PAX3<\/jats:italic>\n                      fusion of BSNS overlaps with that of other tumors, e.g., alveolar rhabdomyosarcoma, further complicates this diagnostic dilemma. DNA methylation profiling has emerged as a helpful tool in classifying poorly differentiated malignancies. We sought to investigate whether conventional BSNS and HGRT retain the same epigenetic signature over time.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Five pure BSNS samples from the initial diagnostic specimens and 4 HGRT components (3 from the long-term recurrence and 1 synchronous) were collected. An immunohistochemical panel of smooth muscle, skeletal muscle, and neural markers was performed and scored as positive or negative. Molecular analyses included RNA-based (4 cases) and DNA-based (2 cases) next-generation sequencing. DNA methylation profiling using the Illumina Infinium EPICv2 microarray was performed, and the methylomes from paired BSNS and HGRT components were compared with a control cohort of BSNS and various high-grade sarcomas.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The tumors arose from 3 females and one male with an age range of 38\u201388\u00a0years (median 70.5\u00a0years old). The time interval between initial BSNS diagnosis to HGRT was between 0 and 14\u00a0years (median 8\u00a0years). The BSNS components were diffusely positive for S-100 and SMA (4\/4), while the HGRT components were positive for desmin (4\/4) myogenin (3\/4) and Myo D1 (1\/1). By RNA sequencing, 2 showed\n                      <jats:italic>PAX3::FOXO1<\/jats:italic>\n                      fusion and 2 showed\n                      <jats:italic>PAX3::MAML3<\/jats:italic>\n                      fusion. Compared to the low-grade BSNS, the HGRT from the same patients acquired additional secondary genomic alterations and significantly more frequent chromosomal arm-level copy number variations. DNA methylation profiling demonstrated that in 3 patients, both low-grade BSNS and HGRT converged with conventional BSNS. In one patient with\n                      <jats:italic>PAX3::FOXO1<\/jats:italic>\n                      fusion, the HGRT from a late recurrence 14\u00a0years since initial diagnosis overlapped epigenetically with embryonal rhabdomyosarcoma.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The epigenetic signature of BSNS is usually preserved in cases that underwent HGRT, even after many years from the initial onset of BSNS. However, in rare instances, the HGRT component may display epigenetic divergence over time.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s12105-026-01923-1","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:25:10Z","timestamp":1779711910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Genomic and Epigenetic Comparative Study of Low-grade Biphenotypic Sinonasal Sarcoma with Metachronous and Synchronous High-grade Rhabdomyosarcomatous Transformation"],"prefix":"10.1007","volume":"20","author":[{"given":"Rayan M.","family":"Sibira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe D\u2019. Almeida","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorva","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Elle","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis","family":"Hattery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilian","family":"Racila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghao","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paari","family":"Murugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine K.","family":"Dermawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"4","key":"1923_CR1","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1097\/PAS.0b013e3182426886","volume":"36","author":"JT Lewis","year":"2012","unstructured":"Lewis JT, Oliveira AM, Nascimento AG et al (2012) Low-grade sinonasal sarcoma with neural and myogenic features: a clinicopathologic analysis of 28 cases. Am J Surg Pathol 36(4):517\u2013525. https:\/\/doi.org\/10.1097\/PAS.0b013e3182426886","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"1923_CR2","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng.2989","volume":"46","author":"X Wang","year":"2014","unstructured":"Wang X, Bledsoe KL, Graham RP et al (2014) Recurrent PAX3-MAML3 fusion in biphenotypic sinonasal sarcoma. Nat Genet 46(7):666\u2013668. https:\/\/doi.org\/10.1038\/ng.2989","journal-title":"Nat Genet"},{"issue":"1","key":"1923_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/gcc.22295","volume":"55","author":"WJ Wong","year":"2016","unstructured":"Wong WJ, Lauria A, Hornick JL, Xiao S, Fletcher JA, Marino-Enriquez A (2016) Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma. Genes Chromosomes Cancer 55(1):25\u201329. https:\/\/doi.org\/10.1002\/gcc.22295","journal-title":"Genes Chromosomes Cancer"},{"issue":"6","key":"1923_CR4","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/his.13045","volume":"69","author":"KJ Fritchie","year":"2016","unstructured":"Fritchie KJ, Jin L, Wang X et al (2016) Fusion gene profile of biphenotypic sinonasal sarcoma: an analysis of 44 cases. Histopathology 69(6):930\u2013936. https:\/\/doi.org\/10.1111\/his.13045","journal-title":"Histopathology"},{"issue":"9","key":"1923_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaoto.2023.1708","volume":"149","author":"A Viramontes","year":"2023","unstructured":"Viramontes A, Mueller N, Gocke CD, Deklotz TR, Ozdemirli M (2023) Novel PAX3::INO80D fusion in biphenotypic sinonasal sarcoma in an adult. JAMA Otolaryngol Head Neck Surg 149(9):849\u2013850. https:\/\/doi.org\/10.1001\/jamaoto.2023.1708","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"1923_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2021.151889","volume":"57","author":"D Bell","year":"2022","unstructured":"Bell D, Phan J, DeMonte F, Hanna EY (2022) High-grade transformation of low-grade biphenotypic sinonasal sarcoma: radiological, morphophenotypic variation and confirmatory molecular analysis. Ann Diagn Pathol 57:151889. https:\/\/doi.org\/10.1016\/j.anndiagpath.2021.151889","journal-title":"Ann Diagn Pathol"},{"issue":"3","key":"1923_CR7","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1055\/s-0042-1755599","volume":"83","author":"S Hasnie","year":"2022","unstructured":"Hasnie S, Glenn C, Peterson JEG, El Rassi ET, McKinney KA (2022) High-grade biphenotypic sinonasal sarcoma: a case report. J Neurol Surg Rep 83(3):e105\u2013e109. https:\/\/doi.org\/10.1055\/s-0042-1755599","journal-title":"J Neurol Surg Rep"},{"issue":"4","key":"1923_CR8","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00428-023-03501-0","volume":"482","author":"A Meyer","year":"2023","unstructured":"Meyer A, Klub\u00ed\u010dkov\u00e1 N, Mosaieby E et al (2023) Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon. Virchows Arch 482(4):777\u2013782. https:\/\/doi.org\/10.1007\/s00428-023-03501-0","journal-title":"Virchows Arch"},{"issue":"5","key":"1923_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1177\/10668969231204961","volume":"32","author":"A Verma","year":"2024","unstructured":"Verma A, Seethala RR, Wang H (2024) Biphenotypic sinonasal sarcoma with high-grade features: a diagnostic challenge. Int J Surg Pathol 32(5):957\u2013961. https:\/\/doi.org\/10.1177\/10668969231204961","journal-title":"Int J Surg Pathol"},{"key":"1923_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2026.106076","volume":"172","author":"YM Gomes","year":"2026","unstructured":"Gomes YM, de Castro JVA, Gomes NM et al (2026) Epigenetic profiling of biphenotypic sinonasal sarcoma across fusion variants and high-grade transformation. Hum Pathol 172:106076. https:\/\/doi.org\/10.1016\/j.humpath.2026.106076","journal-title":"Hum Pathol"},{"issue":"11","key":"1923_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100594","volume":"37","author":"JK Dermawan","year":"2024","unstructured":"Dermawan JK, Malik F, Gross JM et al (2024) Novel PAX3::MAML3 fusion identified in alveolar rhabdomyosarcoma, using DNA methylation profiling to expand the genetic spectrum of \u201cFusion-Positive\u201d cases. Mod Pathol 37(11):100594. https:\/\/doi.org\/10.1016\/j.modpat.2024.100594","journal-title":"Mod Pathol"},{"key":"1923_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01649-w","volume":"11","author":"MR Clay","year":"2021","unstructured":"Clay MR, Patel A, Tran Q et al (2021) Methylation profiling reveals novel molecular classes of rhabdomyosarcoma. Sci Rep 11:22213. https:\/\/doi.org\/10.1038\/s41598-021-01649-w","journal-title":"Sci Rep"},{"issue":"1","key":"1923_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34815-3","volume":"13","author":"P Jurmeister","year":"2022","unstructured":"Jurmeister P, Gl\u00f6\u00df S, Roller R et al (2022) DNA methylation-based classification of sinonasal tumors. Nat Commun 13(1):7148. https:\/\/doi.org\/10.1038\/s41467-022-34815-3","journal-title":"Nat Commun"},{"issue":"10","key":"1923_CR14","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/s41379-019-0285-x","volume":"32","author":"S Dogan","year":"2019","unstructured":"Dogan S, Vasudevaraja V, Xu B et al (2019) DNA methylation-based classification of sinonasal undifferentiated carcinoma. Mod Pathol 32(10):1447\u20131459. https:\/\/doi.org\/10.1038\/s41379-019-0285-x","journal-title":"Mod Pathol"},{"issue":"4","key":"1923_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29511","volume":"69","author":"JH Haduong","year":"2022","unstructured":"Haduong JH, Heske CM, Allen-Rhoades W et al (2022) An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children\u2019s Oncology Group clinical trials. Pediatr Blood Cancer 69(4):e29511. https:\/\/doi.org\/10.1002\/pbc.29511","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"1923_CR16","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/hed.26150","volume":"42","author":"KJ Contrera","year":"2020","unstructured":"Contrera KJ, Woody NM, Rahman M, Sindwani R, Burkey BB (2020) Clinical management of emerging sinonasal malignancies. Head Neck 42(8):2202\u20132212. https:\/\/doi.org\/10.1002\/hed.26150","journal-title":"Head Neck"},{"issue":"12","key":"1923_CR17","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1097\/PAS.0000000000002300","volume":"48","author":"AE Sharma","year":"2024","unstructured":"Sharma AE, Dermawan JK, Chiang S, Wexler LH, Antonescu CR (2024) Botryoid-type embryonal rhabdomyosarcoma: a comprehensive clinicopathologic and molecular appraisal with cross-comparison to its conventional-type counterpart. Am J Surg Pathol 48(12):1557\u20131567. https:\/\/doi.org\/10.1097\/PAS.0000000000002300","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"1923_CR18","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/ng1193-230","volume":"5","author":"N Galili","year":"1993","unstructured":"Galili N, Davis RJ, Fredericks WJ et al (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5(3):230\u2013235. https:\/\/doi.org\/10.1038\/ng1193-230","journal-title":"Nat Genet"},{"issue":"21","key":"1923_CR19","first-page":"5108","volume":"53","author":"DN Shapiro","year":"1993","unstructured":"Shapiro DN, Sublett JE, Li B, Downing JR, Naeve CW (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53(21):5108\u20135112","journal-title":"Cancer Res"},{"issue":"6","key":"1923_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/PAS.0000000000001238","volume":"43","author":"F Le Loarer","year":"2019","unstructured":"Le Loarer F, Laffont S, Lesluyes T et al (2019) Clinicopathologic and molecular features of a series of 41 biphenotypic sinonasal sarcomas expanding their molecular spectrum. Am J Surg Pathol 43(6):747\u2013754. https:\/\/doi.org\/10.1097\/PAS.0000000000001238","journal-title":"Am J Surg Pathol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01923-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-026-01923-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-026-01923-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T12:25:11Z","timestamp":1779711911000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-026-01923-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1923"],"URL":"https:\/\/doi.org\/10.1007\/s12105-026-01923-1","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"27 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research was approved by the Institutional Review Board at the University of Minnesota and Cleveland Clinic.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"49"}}